test

David Kim

@Paradigm Biocapital Advisors Lp

Latest period2024 - Q3ReportedManaged Assets$2.956BTotal holdings31
Assets growth rate13.13%Assets growth rate (2-Q avg)2.56%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Paradigm Biocapital Advisors Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 31 positions.

Assets under management

The assets under management (AUM) of Paradigm Biocapital Advisors Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 2.956B in assets, with a quarterly growth rate of 13.13% and a 2-quarter average growth rate of 2.56%. The portfolio is managed by David Kim, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
VERAVera Therapeutics Inc
Recent Activity
New Position
1.65%
$48.481M
1.097M shares@ $44.2 avg price
MLTXMoonlake Immunotherapeutics
Recent Activity
New Position
1.59%
$46.965M
931,480 shares@ $50.43 avg price
BGNEBeigene Ltd
Recent Activity
New Position
1.53%
$44.977M
200,336 shares@ $224.51 avg price
SYRESpyre Therapeutics Inc
Recent Activity
New Position
1.27%
$37.28M
1.268M shares@ $29.41 avg price
PLRXPliant Therapeutics Inc
Recent Activity
New Position
1.18%
$34.801M
3.104M shares@ $11.21 avg price
KROSKeros Therapeutics Inc
Recent Activity
New Position
1.04%
$30.489M
525,037 shares@ $58.08 avg price
ORKAOruka Therapeutics Inc
Recent Activity
New Position
0.6%
$17.639M
719,660 shares@ $24.52 avg price